|
||
|
Cardiovascular Benefits of Aggressive Cholesterol-Lowering Therapy Provided by: Impact Education, LLC Purpose Statement A 10-year follow up of the original Lipid Treatment Assessment Project (L-TAP) survey was recently published. Overall, 73% of patients reached their LDL-C goal; in high-risk patients, the rate was 67%. Despite this improvement, in high-risk patients (i.e.,... |
|
|
Management of Insulin Dependent Diabetes Provided by: The Ohio State University Medical Center Description According to the National Institutes of Health, with Type 1 diabetes, the pancreas does not make insulin. Over time, high blood glucose can lead to serious problems with the heart, eyes, kidneys, nerves, and gums and teeth. Objectives Upon completion of this... |
|
|
Management of Hyperlipidemia Provided by: Harvard Medical School Abnormalities in lipid metabolism contribute to increased risk for developing coronary heart disease and other forms of vascular disease. This course will review current guidelines for patients with a variety of lipid disorders.... |
|
|
|
Genetics: Familial Hypercholesterolemia Provided by: Harvard Medical School Acknowledgement: This course is supported by educational grants from Celera and the Applera Charitable Foundation. The differential diagnosis of early coronary artery disease contains a number of genetic and environmental eitiologies. This course will review one important... |
|
|
Acute Myocardial Infarction: Reducing the Risk of Missed Diagnosis Provided by: Medical Interactive Community Acute Myocardial Infarction (AMI) often presents clinically in an evolving and confounding manner, creating a risk-laden situation for both patient and physician. Missed or delayed diagnosis is the most common medical misadventure for primary care and emergency physicians. ... |
|
|
Clinical Utility of Non-HDL-Cholesterol in the Management of Dyslipidemia Provided by: Johns Hopkins School of Medicine The Johns Hopkins University School of Medicine Self-Assessment Program (JHU-SAPâ„¢) is a clinical problem-solving, evidence-based continuing education program of active engagement. It is designed to objectively assess and strengthen your knowledge of non-HDL-cholesterol and... |
|
|
|
Professional Liability Risks for Family and General Practice Provided by: Medical Interactive Community Primary care physicians are in short supply, posing the risk of patient overload and increased medical error. Malpractice claims for Family and General Practitioners are on the rise. This Internet presentation reviews the most common medical misadventures for Family and Gene... |
|
|
Management of Dyslipidemias: NCEP ATP III 2011 Updates and Looking Beyond LDL Provided by: CRM Healthcare Management of cardiovascular disease is a rapidly changing area of clinical practice, with emerging research and practice altering widely accepted tenets. While the importance of treating dyslipidemias based on cardiovascular risk factors is highlighted by the NCEP ATP III ... |
|
|
Lipid Management Provided by: Ohio Northern University Objectives: 1. Review the pathophysiology of cholesterol homestasis. 2. Indentify tradional cardiac risk factors. 3. Determine appropriate lipid management goals based on current guidelines. 4. Recommend appropriate therapy for lipid ;management based on current gu... |
|
|
|
Management of Myocardial Infarction Provided by: The Ohio State University Medical Center Description According to National Institutes of Health, most heart attacks are caused by a blood clot that blocks one of the coronary arteries. The coronary arteries bring blood and oxygen to the heart. If the blood flow is blocked, the heart starves for oxygen and heart ce... |
|
|
Best Practices in Primary Care: Dyslipidemia and the Chronic Kidney Disease Patient Provided by: Primary Issues Program Overview Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among people with chronic kidney disease (CKD). While the link between CVD and CKD is apparent, primary care providers are not effectively screening and treating patients with rena... |
|
|
How Thick is Too Thick for your Arteries? Ezetimibe vs Niacin for Cardiovascular Risk Reduction? Provided by: Pharmacy Society of Wisconsin * Compare second-line lipid lowering agents for special patient populations * Assess carotid artery media thickness as a clinical endpoint * Evaluate the primary literature of ezetimibe versus niacin as a guide for therapy management of cardiovascular risk reduction... |
|
|
|
Founder Effect in Familial Hypercholesterolemia (FH): A Focus on Early Detection and Treatment to Prevent Premature CHD in FH
Provided by: Primary Issues Program Overview Familial hypercholesterolemia (FH) is a common autosomal dominant genetic disorder associated with premature cardiovascular disease. The prevalence of heterozygous FH is as high as 1 in 67 for some founder populations such as Ashkenazi Jewish, French Canadi... |
|
